Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Patients”

Showing 20 of 0 results

Not applicableStudy completedNCT00002443
What this trial is testing

The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 780
Large-scale testing (Phase 3)Study completedNCT00002416
What this trial is testing

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 390
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Post-approval studies (Phase 4)Study completedNCT01702090
What this trial is testing

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Who this might be right for
HIV-1
Janssen-Cilag Ltd. 10
Not applicableStudy completedNCT00000890
What this trial is testing

Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Study completedNCT00743340
What this trial is testing

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

Who this might be right for
HIV-1 Infection
Gilead Sciences 50
Not applicableStudy completedNCT00002197
What this trial is testing

1592U89 in HIV-Infected Children

Who this might be right for
HIV Infections
Glaxo Wellcome 250
Testing effectiveness (Phase 2)Study completedNCT00071097
What this trial is testing

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 330
Early research (Phase 1)Study completedNCT02269605
What this trial is testing

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment

Who this might be right for
HIV Infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 12
Not applicableApproved For MarketingNCT00933205
What this trial is testing

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Who this might be right for
HIV Infections
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT00002419
What this trial is testing

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Who this might be right for
HIV Infections
Gilead Sciences 25
Large-scale testing (Phase 3)Study completedNCT00255099
What this trial is testing

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Who this might be right for
HIV
Tibotec Pharmaceuticals, Ireland 593
Post-approval studies (Phase 4)Looking for participantsNCT07357584
What this trial is testing

Efficacy and Safety of Doravirine in the Rapid Initiation

Who this might be right for
HIV-1-infection
Fundación Huésped 100
Large-scale testing (Phase 3)Study completedNCT02157311
What this trial is testing

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 100
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Not applicableUnknownNCT02343887
What this trial is testing

CogStim, a Pilot Study : Cognitive Rehabilitation Management of HIV-1 Mild Cognitively Impaired Patients Controlled With Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique Hopitaux De Marseille 60
Testing effectiveness (Phase 2)Study completedNCT00967187
What this trial is testing

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

Who this might be right for
HIV Infections
Myrexis Inc. 32
Testing effectiveness (Phase 2)UnknownNCT00017992
What this trial is testing

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 100
Not applicableStudy completedNCT00096824
What this trial is testing

Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 860
Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation